within Pharmacolibrary.Drugs.ATC.N;

model N02AJ08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0004166666666666667,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AJ08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Codeine and ibuprofen is a fixed-dose combination analgesic medication used for the treatment of acute moderate to severe pain when treatment with either ibuprofen or codeine alone is inadequate. Codeine is an opioid analgesic, while ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). The combination is approved and marketed in several countries.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for healthy adult subjects after a single oral dose, based on published PK values of each component when used alone, as no clinical pharmacokinetic study of the fixed combination has been published.</p><h4>References</h4><ol><li><p>Thigpen, JC, et al., &amp; Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. <i>European journal of drug metabolism and pharmacokinetics</i> 44(5) 591–609. DOI:<a href=&quot;https://doi.org/10.1007/s13318-019-00552-0&quot;>10.1007/s13318-019-00552-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31006834/&quot;>https://pubmed.ncbi.nlm.nih.gov/31006834</a></p></li><li><p>Laneury, JP, et al., &amp; Molinier, P (1998). Comparative bioavailability study of codeine and ibuprofen after administration of the two products alone or in association to 24 healthy volunteers. <i>European journal of drug metabolism and pharmacokinetics</i> 23(2) 185–189. DOI:<a href=&quot;https://doi.org/10.1007/BF03189337&quot;>10.1007/BF03189337</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9725479/&quot;>https://pubmed.ncbi.nlm.nih.gov/9725479</a></p></li><li><p>Wiffen, PJ, et al., &amp; Moore, RA (2017). Tramadol with or without paracetamol (acetaminophen) for cancer pain. <i>The Cochrane database of systematic reviews</i> 5(5) CD012508–None. DOI:<a href=&quot;https://doi.org/10.1002/14651858.CD012508.pub2&quot;>10.1002/14651858.CD012508.pub2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28510996/&quot;>https://pubmed.ncbi.nlm.nih.gov/28510996</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AJ08;
